Search results
AstraZeneca's COVID prevention drug meets primary goals in late-stage study
Reuters· 6 hours agoAstraZeneca's investigational COVID-19 prevention therapy met its primary goals in a late-stage...
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 6 days agoSanofi agreed to pay Novavax $500 million upfront, with another $700 million in possible payments...
Covid face masks ‘did not stop spread of Omicron’
The Telegraph via Yahoo News· 18 hours agoThe mutations to the Covid virus in the Omicron variant led to it being highly contagious and more capable of escaping vaccine-induced immunity. Boris...
Opinion | Now is the time to talk about vaccines, but Covid-19 leaves polarising legacy
South China Morning Post· 2 days agoIn the US, drug makers were given immunity from lawsuits under agreements with the government, which...
The Silence Around Covid Vaccine Injuries
The Intercept· 3 days agoThis week on Deconstructed, Wightman shares his story with Ryan Grim. Days after receiving an AstraZeneca Covid-19 vaccine in 2021, Wightman ...
Earnings call: GeoVax reports progress on key vaccine trials By Investing.com
Investing.com· 21 hours agoCEO David Dodd discussed significant advancements in the company's Phase 2 clinical trials,...
Allucent Receives BARDA-Funded Project NextGen Award to Support a COVID-19 Vaccine Decentralized...
WKBN 27 Youngstown· 19 hours agoAuthority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS). Funding for this award was received under ...
Aaron Rodgers praises Vladimir Putin as 'smart' in Tucker Carlson interview
NBC Universal via AOL· 1 day agoNFL star Aaron Rodgers praised Russian President Vladimir Putin and railed against Covid-19 vaccines...
Are new COVID variants — called ‘FLiRT’ — spreading in California? A UC doctor explains
The Sacramento Bee· 14 hours agoAnd why are they being called “FLiRT”? Dr. Peter Chin-Hong at UC San Francisco breaks it down.
French, US drug firms team up for Covid-flu shot
Medical Xpress· 6 days agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialize Novavax's COVID-19 vaccine worldwide, except in ...